GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.5206
-0.0191 (-3.54%)
At close: Nov 6, 2025, 4:00 PM EST
0.5208
+0.0002 (0.04%)
After-hours: Nov 6, 2025, 5:03 PM EST
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $15.46 million as of November 6, 2025. Its market cap has decreased by -19.01% in one year.
Market Cap
15.46M
Enterprise Value
12.94M
1-Year Change
-19.01%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since May 13, 2019, GeoVax Labs's market cap has increased from $1.04M to $15.46M, an increase of 1,381.31%. That is a compound annual growth rate of 51.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 16.03M | -31.21% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.01% |
| Dec 31, 2020 | 12.03M | 6,734.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.74B |
| Johnson & Johnson | 448.76B |
| AbbVie | 374.44B |
| UnitedHealth Group | 302.36B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |